Cadrenal Therapeutics(US:CVKD)2024-08-08 20:05Form 8-K Current Report Item 2.02 Results of Operations and Financial Condition Cadrenal Therapeutics, Inc. announced Q2 2024 financial results via a press release, furnished but not filed with the SEC, limiting legal liability - The company issued a press release on August 7, 2024, which included financial information for the fiscal quarter ended June 30, 20242 - The information in the press release (Exhibit 99.1) is not considered "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, which limits certain legal liabilities3 Item 9.01 Financial Statements and Exhibits This section details exhibits furnished with the Form 8-K, including the August 7, 2024 press release and interactive data file Exhibits Furnished with the Report | Exhibit Number | Description | | :--- | :--- | | 99.1 | Press Release, issued by Cadrenal Therapeutics, Inc. on August 7, 2024 | | 104 | Cover Page Interactive Data File (embedded within the inline XBRL document) | Signatures The Form 8-K was officially signed by Quang Pham, Chairman and CEO of Cadrenal Therapeutics, Inc., on August 8, 2024 - The Form 8-K was signed and authorized by Quang Pham, Chairman and Chief Executive Officer, on August 8, 202456